Most likely safe to use in nursing females
But depending on your current needs, one may be better for you than the other
However, patients with low BSA psoriasis and burdensome symptoms who are candidates for biologic therapy (according to the clinicians judgement) may not meet a payers criteria for eligibility to receive advanced psoriasis treatment options [4, 9, 23, 28] Current International Psoriasis Council (IPC), American Academy of Dermatology, and National Psoriasis Foundation treatment guidelines recommend that indicators of psoriasis disease burden beyond BSA, including involvement of high-impact sites and failure of topical therapies, be considered when determining whether patients are eligible for systemic treatment [3, 4]
For chronic conditions, some people use longer cycles
What are warning signs to watch for
Liraglutide and dulaglutide, as well as oral semaglutide and liraglutide, appear to offer comparable glycemic control
